Abstract
The ability of patients to improve glycemic control depends partly on their ability to interpret and act on blood glucose results. We investigated whether switching people with diabetes to blood glucose meters (BGMs) featuring a color range indicator (CRI) could improve glycemic control compared to remaining on their current BGM without color. 163 adults with type 1 (T1D) or type 2 diabetes (T2D) and a hemoglobin A1c (A1c) of 7.5-11% were randomized to: One Touch Verio™ (Verio), OneTouch Verio Flex™ (Flex), or controls remaining on their current BGM. Diabetes nurses had standard conversations about diabetes management with all subjects at baseline. No changes in medication, insulin dosing, or SMBG frequency were recommended. After 12 weeks, subjects who switched to Verio or Flex meters with CRI (n = 108) had a mean change in A1c 0.36% lower than controls (n = 55) ( P = .017). A1c reductions were greatest in T1D subjects (n = 45), with a decrease of 0.50% ( P = .004). T1D subjects using Verio meters (n = 25) contributed a 0.59% reduction compared to controls ( P < .008), whereas T1D subjects using Flex meters (n = 20) had a clinical meaningful reduction in A1c of 0.40% without reaching statistical significance ( P > .05). Verio ...Continue Reading
References
Jun 15, 2007·Diabetes Technology & Therapeutics·Lori M B LaffelLisa K Volkening
Jul 21, 2007·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Angela FagerlinDylan M Smith
May 21, 2008·Annals of Internal Medicine·Kerri CavanaughRussell L Rothman
Jan 29, 2011·Diabetes Care·William H PolonskyRobin S Wagner
Dec 14, 2011·Current Medical Research and Opinion·William H PolonskySteven V Edelman
Sep 28, 2012·Diabetes Technology & Therapeutics·Richard M BergenstalWilliam A Fisher
Feb 5, 2013·Diabetes Care·Kellee M MillerUNKNOWN T1D Exchange Clinic Network
Mar 12, 2013·Scandinavian Journal of Clinical and Laboratory Investigation·Karin LittmannJohanna Westerlund
Mar 26, 2013·Diabetes Research and Clinical Practice·Josie M M EvansJulia Lawton
Jun 6, 2013·Diabetes Care·Emanuele BosiUNKNOWN PRISMA Study Group
Aug 6, 2013·Journal of Diabetes Science and Technology·Mike GradyAparna Srinivasan
Feb 6, 2015·Journal of Diabetes Science and Technology·Mike GradyLaurence B Katz
Dec 22, 2015·Journal of Diabetes Science and Technology·Mike GradyLaurence B Katz
May 28, 2016·Expert Review of Medical Devices·Laurence B KatzHilary Cameron
Nov 3, 2016·Journal of Diabetes Science and Technology·Mike GradyBrian L Levy
Nov 3, 2016·Journal of Diabetes Science and Technology·Marc C Torjman
Dec 22, 2016·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Thomas HaakGerry Rayman
Apr 27, 2017·Journal of Diabetes Science and Technology·Oliver SchnellMichael Hummel
Oct 14, 2017·Diabetes Technology & Therapeutics·Pablo MoraBettina Petersen
Aug 7, 2017·JMIR Diabetes·Mike GradyBrian Leonard Levy
Citations
Aug 11, 2018·Journal of Diabetes Science and Technology·Andjela T Drincic
Mar 29, 2019·Journal of Diabetes Science and Technology·Katharina FritzenOliver Schnell
Jun 18, 2020·Journal of Diabetes Science and Technology·Ayman Al HayekMohamed Al Dawish
Aug 11, 2020·Journal of Diabetes Science and Technology·Deborah A Greenwood, Mike Grady
Aug 25, 2020·Journal of Diabetes Science and Technology·Mike GradyLaurence B Katz
Aug 25, 2020·Journal of Diabetes Science and Technology·Juliette AgnahOliver Schnell
Aug 14, 2020·Journal of Diabetes Science and Technology·David ShearerMalinda Peeples
Mar 21, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Douglas A RobertsonTimothy C Warren
Aug 8, 2019·Journal of Diabetes Science and Technology·Katharina FritzenOliver Schnell
Jul 5, 2019·JMIR Human Factors·Mike GradyOliver Schnell
Dec 4, 2020·Curēus·Ayman Al HayekMohamed Al Dawish
Oct 30, 2021·Journal of Diabetes Science and Technology·Richard M BergenstalLutz Heinemann